Costs of venovenous extracorporeal membrane oxygenation (VV-ECMO) and its potential contribution to quality-adjusted life years: a mixed-methods study protocol.

Cost Eff Resour Alloc · 2026 · PMC13151395 · PMID 42092982

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In Germany, VV-ECMO use increased by 236% from 2007 to 2018, rising from 825 to 2,768 applications, indicating a significant trend in managing severe respiratory failure [ 5 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.